Amylase 16600 UNT / lipase 5000 UNT / protease 18800 UNT Delayed Release Oral Capsule [Lipram]
RxNorm 809329
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 809329 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: amylase 16600 UNT / lipase 5000 UNT / protease 18800 UNT Delayed Release Oral Capsule [Lipram].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 16600 UNT / lipase 5000 UNT / protease 18800 UNT Delayed Release Oral Capsule [Lipram]
(Atom ID: 12361148)
SY
Synonym (SY):
Lipram CR5 (amylase 16,600 UNT / lipase 5000 UNT / protease 18,750 UNT) Delayed Release Oral Capsule
(Atom ID: 11845227)
SY
Synonym (SY):
Lipram CR5 (amylases 16,600 UNT / lipase 5000 UNT / endopeptidases 18,750 UNT) Delayed Release Oral Capsule
(Atom ID: 11845228)
SY